3 recruiting, 2 completed, 1 unknown. 3 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 2, Unknown 1 |
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 1 | Recruiting 1 |
Follow Cetuximab injection: new trials by email Literature Review of Cetuximab injection trials Research Report on Cetuximab injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study of Second-line Treatment in Advanced Colorectal Cancer With Chemotherapy With Bevacizumab or Cetuximab irinotecan liposome (II), fluorouracil, cetuximab - Colorectal Cancer Metastatic | Phase 2 | Recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 100 | 2024-11-12 | 2025-12-22 |
| Clinical Trial of SIBP-03 in Patients With Head and Neck Squamous Cell Carcinoma HER3 Monoclonal antibodies-Dose A, HER3 Monoclonal antibodies-Dose B, HER3 Monoclonal antibodies-Dose C - Head and Neck Squamous Cell Carcinoma | Phase 2 | Recruiting | Shanghai Institute Of Biological Products | 81 | 2024-09-27 | 2026-01-16 |
| A Study to Evaluate MRG003 vs Cetuximab/Methotrexate in in the Treatment of Patients With RM-SCCHN MRG003, Cetuximab injection, Methotrexate Injection - Squamous Cell Carcinoma of the Head and Neck | Phase 3 | Recruiting | Lepu Biopharma Co., Ltd. | 180 | 2023-04-04 | 2026-09-04 |
| Avelumab Combined With Cetuximab and Irinotecan for Treatment Refractory Metastatic Colorectal Microsatellite Stable Cancer Avelumab, Cetuximab Injection, Irinotecan - Colorectal Neoplasms, Malignant | Phase 2 | Unknown | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 59 | 2018-10-03 | 2020-10-22 |
| A Preliminary Clinical Study on the Pharmacokinetics and Safety of CDP1 in Patients With Advanced CRC or HNSCC anti-EGFR monoclonal antibody, Cetuximab injection - Colorectal Cancer | Phase 1 | Completed | Dragonboat Biopharmaceutical Company Limited | 18 | 2018-07-01 | 2026-07-06 |
| Clinical Trial to Evaluate Pharmacokinetics,Safety and Immunogenicity of Single Injection of CDP1 to Healthy Volunteers Compared to Erbitux anti-EGFR monoclonal antibody, Cetuximab injection - Healthy Volunteers | Phase 1 | Completed | Dragonboat Biopharmaceutical Company Limited | 84 | 2017-04-19 | 2026-06-26 |
Squamous Cell Carcinoma of Head and Neck (2) · Colonic Neoplasms (1) · Colorectal Neoplasms (1)
Dragonboat Biopharmaceutical Company Limited (2) · Cliniques universitaires Saint-Luc- Université Catholique de Louvain (1) · Lepu Biopharma Co., Ltd. (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1) · Shanghai Institute Of Biological Products (1)
China (5) · Belgium (1)
Li Jin, doctor (1) · Ye Guo, Doctor (1) · Ye Guo, PhD (1)